Revolutionary nasal spray offers hope by potentially delaying Alzheimer's progression through cutting-edge neurological ...

A major trial in frontotemporal dementia patients has found that oxytocin can help improve symptoms of apathy. A new study ...

Researchers delivered a dose of the “love hormone” oxytocin via a nasal spray to participants and found that it decreased ...

They then used the nasal spray on several mouse models and observed them over time to see if it made a difference. The research team found that the mice exhibited reduced dementia symptoms.

A new study suggests people who take longer to enter the dream stage of the sleep cycle are more likely to develop dementia.

The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S.

A new study has found that treatment with oxytocin – a hormone associated with empathy – can address apathy symptoms in ...